Kazumi Nishino: Cancer Fighting Innovations

Apr 3, 2020 · case presentation: We report a case of favorable response to pembrolizumab in a patient with disease progression during durvalumab consolidation therapy after. Kazumi nishino's 194 research works with 2,067 citations and 5,260 reads, including: Jan 24, 2021 · experiments in mice showed promising results: General tumor shrinkage, and complete regression of 3 out of 8 tumors.

Sep 11, 2020 · here, we report the primary results of the nsclc part of a randomized controlled trial evaluating reactive topical corticosteroid strategies in patients with nsclc and crc.